Acadian Asset Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
3,042,238
-92,348
| -3% | -$65.9K | ﹤0.01% | 804 |
|
|
2025
Q1 | $2.04M | Buy |
3,134,586
+1,382,661
| +79% | +$899K | 0.01% | 751 |
|
|
2024
Q4 | $3.22M | Buy |
1,751,925
+142,051
| +9% | +$261K | 0.01% | 645 |
|
|
2024
Q3 | $5.57M | Buy |
1,609,874
+34,916
| +2% | +$121K | 0.02% | 481 |
|
|
2024
Q2 | $4.61M | Buy |
1,574,958
+370,705
| +31% | +$1.09M | 0.01% | 525 |
|
|
2024
Q1 | $6.8M | Buy |
1,204,253
+281,224
| +30% | +$1.59M | 0.02% | 393 |
|
|
2023
Q4 | $3.96M | Buy |
923,029
+149,162
| +19% | +$640K | 0.02% | 517 |
|
|
2023
Q3 | $2.68M | Buy |
773,867
+119,399
| +18% | +$414K | 0.01% | 604 |
|
|
2023
Q2 | $3.04M | Sell |
654,468
-32,767
| -5% | -$152K | 0.01% | 584 |
|
|
2023
Q1 | $3.17M | Buy |
687,235
+125,407
| +22% | +$579K | 0.01% | 581 |
|
|
2022
Q4 | $4.54M | Sell |
561,828
-69,972
| -11% | -$565K | 0.02% | 470 |
|
|
2022
Q3 | $3.5M | Sell |
631,800
-29,815
| -5% | -$165K | 0.02% | 499 |
|
|
2022
Q2 | $3.45M | Buy |
661,615
+423,458
| +178% | +$2.21M | 0.02% | 501 |
|
|
2022
Q1 | $1.96M | Buy |
238,157
+94,439
| +66% | +$776K | 0.01% | 669 |
|
|
2021
Q4 | $2.14M | Sell |
143,718
-38,570
| -21% | -$574K | 0.01% | 642 |
|
|
2021
Q3 | $3.44M | Sell |
182,288
-40,181
| -18% | -$759K | 0.01% | 540 |
|
|
2021
Q2 | $4.14M | Sell |
222,469
-14,924
| -6% | -$277K | 0.02% | 517 |
|
|
2021
Q1 | $5.4M | Buy |
237,393
+117,230
| +98% | +$2.67M | 0.02% | 457 |
|
|
2020
Q4 | $2.61M | Sell |
120,163
-6,747
| -5% | -$146K | 0.01% | 686 |
|
|
2020
Q3 | $1.28M | Buy |
126,910
+33,344
| +36% | +$335K | 0.01% | 813 |
|
|
2020
Q2 | $726K | Buy |
93,566
+4,620
| +5% | +$35.8K | ﹤0.01% | 1065 |
|
|
2020
Q1 | $908K | Buy |
88,946
+43,499
| +96% | +$444K | 0.01% | 823 |
|
|
2019
Q4 | $501K | Buy |
45,447
+14,736
| +48% | +$162K | ﹤0.01% | 1072 |
|
|
2019
Q3 | $279K | Buy |
30,711
+21,653
| +239% | +$197K | ﹤0.01% | 1236 |
|
|
2019
Q2 | $103K | Buy |
9,058
+8,440
| +1,366% | +$96K | ﹤0.01% | 1365 |
|
|
2019
Q1 | $7K | Buy |
+618
| New | +$7K | ﹤0.01% | 1889 |
|